RT Journal Article
SR Electronic
T1 Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB
JF BMJ Global Health
JO BMJ Global Health
FD BMJ Publishing Group Ltd
SP e002061
DO 10.1136/bmjgh-2019-002061
VO 5
IS 4
A1 Kalipso Chalkidou
A1 Adrian Towse
A1 Rachel Silverman
A1 Martina Garau
A1 Ganesh Ramakrishnan
YR 2020
UL http://gh.bmj.com/content/5/4/e002061.abstract
AB